Clinical Trial Update: Open-label Study to Assess the Safety and Efficacy of Psilocybin With Psychotherapy in Adult Participants With Fibromyalgia [Phase 2]

View source ↗

Summary

Results from a Phase 2 open-label study evaluating psilocybin with psychotherapy in adult participants with fibromyalgia have been completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Kevin Boehnke | Conditions: Fibromyalgia | Phase 2 | Status: COMPLETED | Results posted: 2025-04-16